NCT02954653 A Study Of PF-06747143, As Single Agent Or In Combination With Standard Chemotherapy In Adult Patients With Acute Myeloid Leukemia Status TERMINATED Phase PHASE1
NCT02952586 Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100) Status TERMINATED Phase PHASE3
NCT02951156 Avelumab In Combination Regimens That Include An Immune Agonist, Epigenetic Modulator, CD20 Antagonist and/or Conventional Chemotherapy in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma (R/R DLBCL) Status TERMINATED Phase PHASE3
NCT02947685 Randomized, Open Label, Clinical Study of the Targeted Therapy, Palbociclib, to Treat Metastatic Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT02947334 Efficacy And Safety Of Bococizumab For Lipid Lowering In Asian Hypercholesterolemia Subjects Status WITHDRAWN Phase PHASE3
NCT02942355 Trial of Anastrozole and Palbociclib in Metastatic HER2-Negative Breast Cancer Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02936154 Study for MR Formulation of PF-06650833 in Healthy Adult Japanese Subjects Status COMPLETED Phase PHASE1
NCT02935998 The Efficacy And Safety Of Intramuscular Ziprasidone For Three Days In Patients With Psychotic Agitation Status UNKNOWN Phase PHASE4
NCT02934022 Adding Maraviroc to the HAART Regimen of Well Controlled HIV-infected Patients Status COMPLETED Phase NA
NCT02933697 Compare Apixaban and Vitamin-K Antagonists in Patients With Atrial Fibrillation (AF) and End-Stage Kidney Disease (ESKD) Status COMPLETED Phase PHASE3
NCT02932774 Randomized, Double Blind, Parallel Group, Placebo Controlled, Multi-Center Study of the Efficacy and Safety of Cetirizine HCl Syrup vs. Loratadine Syrup vs. Placebo in Treatment of Children With Seasonal Allergic Rhinitis (SAR) Status COMPLETED Phase PHASE4
NCT02929576 Efficacy and Safety Study of Enzalutamide in Combination With Paclitaxel Chemotherapy or as Monotherapy Versus Placebo With Paclitaxel in Patients With Advanced, Diagnostic-Positive, Triple-Negative Breast Cancer Status WITHDRAWN Phase PHASE3
NCT02928575 Combining Sunitinib, Temozolomide and Radiation to Treat Patients Diagnosed With Glioblastoma Status UNKNOWN Phase PHASE2
NCT02928224 Study of Encorafenib + Cetuximab Plus or Minus Binimetinib vs. Irinotecan/Cetuximab or Infusional 5-Fluorouracil (5-FU)/Folinic Acid (FA)/Irinotecan (FOLFIRI)/Cetuximab With a Safety Lead-in of Encorafenib + Binimetinib + Cetuximab in Patients With BRAF V600E-mutant Metastatic Colorectal Cancer Status COMPLETED Phase PHASE3
NCT02927535 Evaluation of TNFα Blockers Monotherapy in Early Rheumatoid Arthritis in France Status COMPLETED Phase N/A
NCT02927509 Evaluation of Tumour Necrosis Factor Alpha (TNFα) Blockers in Early Rheumatoid Arthritis in France Status COMPLETED Phase N/A